Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Phase 1 Safety and Pharmacodynamic Results of VRDN-001, a Full Antagonist Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R) in Development for Thyroid Eye Disease (TED)

Tuberous Sclerosis Complex in Adulthood: A Descriptive Cohort Retrospective Review

Recurrent PRES after initiation of R-EPOCH & Methotrexate: A Case Study.